학술논문
The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy
Document Type
Article
Author
Source
In: Frontiers in Immunology . (Frontiers in Immunology, 2023, 14)
Subject
Language
English
ISSN
16643224